全文获取类型
收费全文 | 42篇 |
免费 | 4篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 1篇 |
妇产科学 | 2篇 |
基础医学 | 12篇 |
临床医学 | 2篇 |
内科学 | 9篇 |
皮肤病学 | 2篇 |
神经病学 | 2篇 |
外科学 | 6篇 |
预防医学 | 4篇 |
药学 | 1篇 |
中国医学 | 1篇 |
肿瘤学 | 3篇 |
出版年
2021年 | 2篇 |
2020年 | 1篇 |
2018年 | 1篇 |
2016年 | 1篇 |
2015年 | 3篇 |
2014年 | 1篇 |
2013年 | 1篇 |
2012年 | 3篇 |
2011年 | 1篇 |
2010年 | 1篇 |
2009年 | 4篇 |
2008年 | 2篇 |
2007年 | 3篇 |
2006年 | 5篇 |
2004年 | 2篇 |
2003年 | 3篇 |
2002年 | 3篇 |
2000年 | 3篇 |
1998年 | 2篇 |
1991年 | 3篇 |
1989年 | 2篇 |
排序方式: 共有47条查询结果,搜索用时 0 毫秒
1.
Initiation of antiretroviral therapy in HIV‐infected adults with skin complaints in northern Tanzania 下载免费PDF全文
Daudi R. Mavura MD MMed E. John Masenga MD MMed Eli Minja MD MMed Henning Grossmann MD MMed John A. Crump MB ChB DTM&H John A. Bartlett MD 《International journal of dermatology》2015,54(1):68-73
Abnormal skin findings are identified in over 90% of human immunodeficiency virus (HIV)‐infected persons globally. A prospective cohort study of HIV‐infected patients with skin complaints commencing antiretroviral therapy (ART) in northern Tanzania was undertaken. Consecutive HIV‐infected subjects presenting with skin complaints, who met criteria for ART initiation, were recruited at a Tanzanian Regional Dermatology Training Center. A single dermatologist evaluated all subjects; baseline skin biopsies were performed, and CD4+ cell counts and plasma HIV RNA levels were measured. All subjects received a fixed‐dose combination of stavudine, lamivudine, and nevirapine. A total of 100 subjects were enrolled; 86 subjects completed six months of follow‐up. Median baseline CD4+ cell counts and plasma HIV RNA levels were 120 cells/μl and 5.2 log10 copies/ml. The most common dermatologic condition was papular pruritic eruption (47%). The median baseline score on the Burn Scale was 38%. After six months, 10 subjects had achieved the complete resolution of skin abnormalities. In those without complete resolution, the median Burn Scale score improved to 7%. Five patients developed new eruptions by month 3, which in two cases were attributed to drug reactions. In the 86 subjects remaining on ART after six months, the median CD4+ cell count had increased to 474 cells/μl, and plasma HIV RNA levels were <400 copies/ml in 85 (99%) subjects. Patients with HIV infection with skin complaints experienced marked clinical improvements following ART initiation. 相似文献
2.
Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. 下载免费PDF全文
R Eren I Lubin D Terkieltaub O Ben-Moshe A Zauberman R Uhlmann T Tzahor S Moss E Ilan D Shouval E Galun N Daudi H Marcus Y Reisner S Dagan 《Immunology》1998,93(2):154-161
An approach to develop fully human monoclonal antibodies in a human/mouse radiation chimera, the Trimera system, is described. In this system, functional human lymphocytes are engrafted in normal strains of mice which are rendered immuno-incompetent by lethal total body irradiation followed by radioprotection with severe combined immunodeficient (SCID) mouse bone marrow. Following transplantation, human lymphocytes colonize murine lymphatic organs and secrete human immunoglobulins. We have established this system as a tool to develop fully human monoclonal antibodies, and applied it for the generation of monoclonal antibodies specific for hepatitis B virus surface antigen. A strong memory response to hepatitis B surface antigen was elicited in Trimera engrafted with lymphocytes from human donors positive for antibodies to hepatitis B surface antigen. The human specific antibody fraction in the Trimera was 10(2)-10(3)-fold higher as compared with that found in the donors. Spleens were harvested from Trimera mice showing high specific-antibody titres and cells were fused to a human-mouse heteromyeloma fusion partner. Several stable hybridoma clones were isolated and characterized. These hybridomas produce high-affinity, IgG, anti-hepatitis B surface antigen antibodies demonstrating the potential of the Trimera system for generating fully human monoclonal antibodies. The biological function and the neutralizing activity of these antibodies are currently being tested. 相似文献
3.
4.
5.
6.
7.
8.
Severity of cognitive impairment as a prognostic factor for mortality and functional recovery of geriatric patients with hip fracture 下载免费PDF全文
9.
The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV. 总被引:16,自引:0,他引:16
Ehud Ilan Joseph Arazi Ofer Nussbaum Arie Zauberman Rachel Eren Ido Lubin Lewis Neville Ofer Ben-Moshe Alberto Kischitzky Amir Litchi Ido Margalit Judith Gopher Samir Mounir Weizhong Cai Nili Daudi Ahamed Eid Oded Jurim Abraham Czerniak Eithan Galun Shlomo Dagan 《The Journal of infectious diseases》2002,185(2):153-161
The lack of small-animal models that are suitable for evaluation of agents used to treat infection with hepatitis C virus (HCV) severely hinders the assessment of potential new therapies for the disease. This study created such a model, termed the "HCV-Trimera" model. The HCV-Trimera model was developed by using lethally irradiated mice, reconstituted with SCID mouse bone marrow cells, in which human liver fragments infected ex vivo with HCV had been transplanted. Viremia (positive-strand HCV RNA levels) in HCV-Trimera mice peaked at approximately day 18 after liver transplantation, and an infection rate of 85% was reached. Viral replication in liver grafts was evidenced by the presence of specific negative-strand HCV RNA. The usefulness of this model for evaluation of anti-HCV agents was demonstrated by the ability of a small molecule (an HCV internal ribosomal entry site inhibitor) and an anti-HCV human monoclonal antibody (HCV AB(XTL)68) to reduce virus loads in HCV-Trimera mice in a dose-dependent manner. 相似文献